797 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint 797 is Orange, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Sun Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 797

Divalproex Sodium Delayed-Release

Imprint:

797

Strength:

250 mg

Color:

Orange

Size:

15.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Sun Pharmaceuticals

Inactive Ingredients:

silicon dioxide
corn starch
povidone k30
hypromellose
titanium dioxide
triacetin
methacrylic acid - ethyl acrylate copolymer (1:1) type a
magnesium silicate
triethyl citrate
sodium bicarbonate
sodium lauryl sulfate
FD&C Yellow No. 6
ferric oxide yellow
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer